APA (7th ed.) Citation

Garcia-Gutierrez, V., Huang, F., Ashaye, A., Dalal, M., Laliman-Khara, V., Breccia, M., . . . Jabbour, E. J. Ponatinib vs. asciminib in post–second-generation tyrosine kinase inhibitor therapy for chronic-phase chronic myeloid leukemia: A matching-adjusted indirect comparison. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Garcia-Gutierrez, Valentin, et al. Ponatinib Vs. Asciminib in Post–second-generation Tyrosine Kinase Inhibitor Therapy for Chronic-phase Chronic Myeloid Leukemia: A Matching-adjusted Indirect Comparison. Frontiers Media S.A.

MLA (9th ed.) Citation

Garcia-Gutierrez, Valentin, et al. Ponatinib Vs. Asciminib in Post–second-generation Tyrosine Kinase Inhibitor Therapy for Chronic-phase Chronic Myeloid Leukemia: A Matching-adjusted Indirect Comparison. Frontiers Media S.A.